Article
De novo design of anti-variant COVID-19 Vaccine
2023-06-20
Abstract excerpt
Recent studies have demonstrated the effectiveness of hybrid SARS-CoV-2 vaccines that combine the wild-type nucleocapsid (N) and Spike (S) proteins. Based on this strategy, we have further enhanced the idea by incorporating the spike protein with mutations from delta and post-delta omicron variants of concern (VOC). Both delta and omicron mark the transition of vaccine driven viral immunity and resistance, so thei...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1b9fff20-4047-554e-81f8-56d4a3ee5f40
- DOI
- 10.22541/au.168726822.26143817/v1
